D
Dawn M. Sievert
Researcher at Centers for Disease Control and Prevention
Publications - 20
Citations - 6456
Dawn M. Sievert is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Staphylococcus aureus & Health care. The author has an hindex of 10, co-authored 18 publications receiving 6067 citations. Previous affiliations of Dawn M. Sievert include Michigan Department of Community Health.
Papers
More filters
Journal ArticleDOI
Antimicrobial-Resistant Pathogens Associated with Healthcare- Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert,Philip Ricks,Jonathan R. Edwards,Amy Schneider,Jean B. Patel,Arjun Srinivasan,Alex Kallen,Brandi Limbago,Scott K. Fridkin +8 more
TL;DR: The frequency of selected antimicrobial resistance patterns among pathogens causing device-associated and procedure-associated healthcare-associated infections reported by hospitals in the National Healthcare Safety Network (NHSN) is described.
Journal ArticleDOI
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.
Soju Chang,Dawn M. Sievert,Jeffrey C. Hageman,Matthew L. Boulton,Fred C. Tenover,Frances P. Downes,Sandip Shah,James T. Rudrik,Guy R. Pupp,William J. Brown,Denise M. Cardo,Scott K. Fridkin +11 more
TL;DR: Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers and carried the vanA resistance gene, which may have come from the vancomycius-resistant Enterococcus faecalis that was also isolated from the patient.
Journal Article
Staphylococcus aureus Resistant to Vancomycin—United States, 2002
Dawn M. Sievert,Matthew L. Boulton,G. Stoltman,David W. Johnson,Mary Grace Stobierski,William J. Brown,W Hafeez,T Lundstrom,E Flanagan,R. Johnson,James E. Mitchell,S Chang +11 more
Journal ArticleDOI
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002–2006
Dawn M. Sievert,Dawn M. Sievert,James T. Rudrik,Jean B. Patel,L. Clifford McDonald,Melinda J. Wilkins,Jeffrey C. Hageman +6 more
TL;DR: In this paper, the authors compared the clinical characteristics, epidemiologic investigations, infection-control evaluations, and microbiologic findings of all 7 cases of vancomycin-resistant Staphylococcus aureus (VRSA) infection in the United States during the period 2002-2006.
Journal ArticleDOI
Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season
Jeffrey C. Hageman,Timothy M. Uyeki,John S. Francis,Daniel B. Jernigan,J. Gary Wheeler,Carolyn B. Bridges,Stephen J. Barenkamp,Dawn M. Sievert,Arjun Srinivasan,Meg Doherty,Linda K. McDougal,George Killgore,Uri Lopatin,Rebecca Coffman,J. Kathryn MacDonald,Sigrid K. McAllister,Gregory E. Fosheim,Jean B. Patel,L. Clifford McDonald +18 more
TL;DR: A confirmed case of St. aureus community-acquired pneumonia in the U.S. has been reported from 9 states, and the number of cases is likely to increase as more people are diagnosed with the disease.